Cleared Traditional

K001728 - HARDY DISK CLARITHROMYCIN

K001728 is the FDA 510(k) clearance for HARDY DISK CLARITHROMYCIN by Hardy Diagnostics. It is a Class 2 Microbiology device (product code JTN) cleared through the Traditional 510(k) pathway after a 50-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2000
Decision
50d
Days
Class 2
Risk

K001728 is an FDA 510(k) clearance for the HARDY DISK CLARITHROMYCIN, 15MCG. Classified as Susceptibility Test Discs, Antimicrobial (product code JTN), Class II - Special Controls.

Submitted by Hardy Diagnostics (Santa Maria, US). The FDA issued a Cleared decision on July 27, 2000 after a review of 50 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.1620 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Hardy Diagnostics devices

Submission Details

510(k) Number K001728 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 07, 2000
Decision Date July 27, 2000
Days to Decision 50 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d faster than avg
Panel avg: 102d · This submission: 50d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code JTN Susceptibility Test Discs, Antimicrobial
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.1620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - JTN Susceptibility Test Discs, Antimicrobial

All 282
Devices cleared under the same product code (JTN) and FDA review panel - the closest regulatory comparables to K001728.
HARDYDISK STREPTOMYCIN, 300MCG
K002368 · Hardy Diagnostics · Oct 2000
HARDYDISK CEFUROXIME, 30MCG
K002656 · Hardy Diagnostics · Oct 2000
HARDYDISK NETILMICIN, 30MCG
K002663 · Hardy Diagnostics · Oct 2000
HARDYDISK CINOXACIN, 100 MCG
K001487 · Hardy Diagnostics · Jun 2000
HARDYDISK CEFOPERAZONE, 75 MCG
K001489 · Hardy Diagnostics · Jun 2000
HARDYDISK CEFONICID, 30 MCG
K001490 · Hardy Diagnostics · Jun 2000